| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010267840 |
| P356 | DOI | 10.1186/1748-717X-7-216 |
| P932 | PMC publication ID | 3551831 |
| P698 | PubMed publication ID | 23244066 |
| P5875 | ResearchGate publication ID | 233937865 |
| P50 | author | Ralph Weichselbaum | Q19668192 |
| P2093 | author name string | Daniel Appelbaum | |
| Steven J Chmura | |||
| Joseph K Salama | |||
| Abhishek A Solanki | |||
| Kamil M Yenice | |||
| Karl Farrey | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial | Q28036747 | ||
| Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group | Q33348775 | ||
| Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 | ||
| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer | Q33913953 | ||
| A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. | Q34282412 | ||
| Can positron emission tomography improve the quality of care for head-and-neck cancer patients? | Q34343320 | ||
| Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group | Q34511070 | ||
| A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions | Q34723820 | ||
| Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. | Q34961039 | ||
| PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response | Q37290872 | ||
| Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study | Q39675331 | ||
| Karnofsky Memorial Lecture. Natural history of small breast cancers | Q40635593 | ||
| FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer | Q42164881 | ||
| Neck neoplasms: MR imaging. Part II. Posttreatment evaluation | Q45117239 | ||
| Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease | Q45170619 | ||
| 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy | Q45245511 | ||
| Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. | Q46531455 | ||
| Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. | Q53363634 | ||
| Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. | Q53637484 | ||
| Soft-tissue changes after head and neck radiation: CT findings | Q69176736 | ||
| Surveillance for recurrent head and neck cancer using positron emission tomography | Q73399592 | ||
| Radiographic response and clinical toxicity following SBRT for stage I lung cancer | Q80550720 | ||
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography | Q130273243 |
| P304 | page(s) | 216 | |
| P577 | publication date | 2012-12-18 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study | |
| P478 | volume | 7 |
| Q37187233 | Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach |
| Q34655878 | Current and emerging treatment options for uveal melanoma |
| Q50331322 | Evaluation of response after SBRT for liver tumors |
| Q37392508 | Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors |
| Q41710571 | Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT). |
| Q38255903 | Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature |
| Q38463103 | Radiation therapy for oligometastatic non-small cell lung cancer |
| Q34124296 | Radical irradiation of extracranial oligometastases |
| Q30453423 | Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm |
| Q38831804 | Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. |
| Q38625125 | The evolving role of radiotherapy in treatment of oligometastatic NSCLC. |
Search more.